# Hu Zhiyuan

> Hu Zhiyuan is a funding round investor at SDIC Fund Management backing Biopharma and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [SDIC Fund Management](https://shizune.co/investors/profile/sdic-fund-management)
- Total investments: 1
- Last investment: Nov 2017
- Lead investor: 100%
- Last updated: Aug 2026

Hu Zhiyuan is a funding round investor at SDIC Fund Management focused on Biopharma and Biotechnology. Hu Zhiyuan - Director of Investment @ SDIC Fund Management

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Zensun (Shanghai) Sci & Tech Co. | Zensun (Shanghai) Sci & Tech Co., Ltd. is a biopharmaceutical company focusing on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs. They discover new medicines using novel disease specific targets and innovative technologies. The patented discoveriesare then developed into therapies. With adherence to the tenet of “healing for life”, we hope to transform the lives of heart failure and cancer patients by providing them with drugs that treat their disease and not the symptoms. Zensun’s current pipeline covers cardiovascular disease treatment, anti-cancer drugs, and treatments for energy metabolism disorders. | $71.9M |  | Nov 16, 2017 |  |

1 of 1 investments shown.

## About SDIC Fund Management

VC Fund · Beijing, China

SDIC Fund Management is a private equity that manages funds and raises nearly 60 billion yuan at present. The management funds cover financial institutions, social security funds, state-owned and private capital, and it is one of the largest professional private equity management institutions in China.

1 contacts available at SDIC Fund Management.

| Name | Title | Profile |
| --- | --- | --- |
| Hu Zhiyuan | Director of Investment | https://shizune.co/investors/profile/hu-zhiyuan |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Hu Zhiyuan invest in?

Hu Zhiyuan invests primarily in Biopharma and Biotechnology startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Hu Zhiyuan last invest?

The most recent investment recorded for Hu Zhiyuan closed in Nov 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co